Recently Featured

Elevance Sues U.S. Government Over $115 Million Medicare Advantage Star Ratings Dispute

August 9, 2026
Elevance Health has initiated legal action against the U.S. government, claiming that recent federal efforts to recalculate its Medicare Advantage quality ratings contradict a prior court ruling, resulting in a financial loss of $115 million for the health insurer. This lawsuit, filed in the U.S. District Court for the Southern District of Georgia, highlights ongoing…

Elixirgen Advances Rare Disease Pipeline Targeting Telomere Biology and DMD

August 9, 2026
Elixirgen Therapeutics is strategically developing a pipeline focused on rare diseases linked to telomere biology disorders (TBD) and Duchenne Muscular Dystrophy (DMD). Founded in 2017, the company is leveraging its proprietary ZSCAN4 technology to target aging-related diseases and mRNA-based therapies. The most advanced candidate, EXG-7001, aims to deliver a full-length dystrophin protein for DMD patients,…

ASMS 2026: Solving Proteomics’ Next Bottleneck

August 9, 2026
At the 74th American Society for Mass Spectrometry (ASMS) Conference in San Diego, the focus was on the advancements in hardware, with vendors unveiling faster acquisition systems and enhanced sensitivity. Key players such as Waters, Thermo Fisher Scientific, and Sciex showcased their latest innovations. However, discussions revealed a shift in the proteomics landscape, where the…

UK Issues Guidance on Non-Exportable Medicines Critical for Domestic Patients

August 9, 2026
The UK government has released guidance outlining specific medicines that cannot be exported or hoarded, emphasizing their critical importance for domestic patients. This directive is a response to ongoing concerns regarding the availability of essential medications within the UK, particularly in light of recent supply chain disruptions exacerbated by global events. Contextually, the guidance aims…

Ongoing Cases